血管
血管性血友病因子
血管
内皮
血栓形成
血运重建
动脉
医学
基底膜
病理
人口
再生(生物学)
组织工程
生物
外科
心脏病学
内科学
细胞生物学
生物医学工程
心肌梗塞
血小板
环境卫生
作者
Nicolas L’Heureux,Nathalie Dusserre,Gerhardt König,B Eichler Victor,Paul Keire,Thomas N. Wight,Nicolas A.F. Chronos,Andrew E. Kyles,Clare R. Gregory,Grant Hoyt,Robert C. Robbins,Todd N. McAllister
出处
期刊:Nature Medicine
[Nature Portfolio]
日期:2006-02-19
卷期号:12 (3): 361-365
被引量:1067
摘要
There is a crucial need for alternatives to native vein or artery for vascular surgery. The clinical efficacy of synthetic, allogeneic or xenogeneic vessels has been limited by thrombosis, rejection, chronic inflammation and poor mechanical properties. Using adult human fibroblasts extracted from skin biopsies harvested from individuals with advanced cardiovascular disease, we constructed tissue-engineered blood vessels (TEBVs) that serve as arterial bypass grafts in long-term animal models. These TEBVs have mechanical properties similar to human blood vessels, without relying upon synthetic or exogenous scaffolding. The TEBVs are antithrombogenic and mechanically stable for 8 months in vivo. Histological analysis showed complete tissue integration and formation of vasa vasorum. The endothelium was confluent and positive for von Willebrand factor. A smooth muscle–specific α-actin–positive cell population developed within the TEBV, suggesting regeneration of a vascular media. Electron microscopy showed an endothelial basement membrane, elastogenesis and a complex collagen network. These results indicate that a completely biological and clinically relevant TEBV can be assembled exclusively from an individual's own cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI